glp-1 agonists in development Market Overview: and the Obesity Market | Blog GLP-1 receptor agonists for individualized

This study aimed to summarize these indicators through a meta-analysis

The research findings Through a retrospective cohort study examining the electronic health records of more than 840,000 breast cancer patients who were diagnosed between 2006 and 2023, the results suggest there is a potential link between GLP-1 RAs and improved outcomes among breast cancer patients who are also obese or have type 2 diabetes

Future research should focus on: Developing oral formulations

doi: 10.1371/journal.pmed.1002051

Our scientific and technical teams provide flexible solutions across the full development cyclefrom early research to regulatory submission

Circadian GLP-1 Secretion in mice is dependent on the intestinal microbiome for maintenance of diurnal metabolic homeostasis